The Tests That Find Prostate Cancer

Prostate cancer is usually found through one or more of three tests: a blood test for a protein called PSA, a digital rectal exam where a doctor feels the prostate with a gloved finger, or an imaging scan. No single test is definitive on its own. If results suggest cancer might be present, a doctor will order a biopsy—a procedure where a needle removes tiny samples of prostate tissue so a pathologist can look for cancer cells under a microscope. The biopsy is the only way to confirm whether cancer is actually there.

The path to diagnosis often starts with screening, which means testing men who have no symptoms. Screening is different from diagnosis—it looks for signs of disease before a man feels sick. Not all men need screening, and the decision to screen depends on age, family history, and personal preference. Once screening or symptoms raise concern, the diagnostic tests follow a specific sequence.

Key Takeaways

  • A PSA blood test and digital rectal exam are the most common first steps, but neither one proves cancer is present.
  • An MRI scan or ultrasound may be ordered to get a closer look at the prostate before a biopsy.
  • A biopsy—removing tiny tissue samples with a needle—is the only test that can confirm prostate cancer.
  • After cancer is confirmed, additional imaging tests determine whether it has spread beyond the prostate.
  • The entire diagnostic process from first test to biopsy results usually takes several weeks.

The PSA Blood Test

PSA stands for prostate-specific antigen, a protein made by the prostate gland. A PSA test measures how much of this protein is in the blood. Higher levels can suggest cancer, but they can also mean the prostate is simply enlarged, inflamed, or infected—conditions that are not cancer. A single PSA result does not diagnose cancer; doctors look at the number itself, how fast it is rising over time, and what other tests show.

PSA levels vary widely among men. There is no single "normal" number that applies to everyone. A result of 4 nanograms per milliliter (ng/mL) has traditionally been used as a cutoff, but some men with cancer have lower levels, and some without cancer have higher ones. Your doctor will interpret your PSA in the context of your age, family history, and any previous PSA results you have had.

The Digital Rectal Exam

In a digital rectal exam (DRE), a doctor inserts a gloved, lubricated finger into the rectum to feel the prostate gland, which sits just in front of the rectum. The exam takes less than a minute. A doctor can feel the size and texture of the prostate and notice any hard spots or lumps that might suggest cancer. Like the PSA test, an abnormal DRE does not prove cancer is present—it is a signal to do more testing.

Some men find the DRE uncomfortable, but it causes no pain or lasting effects. It is often done at the same visit as a PSA blood draw. Together, these two tests have been the standard screening approach for decades, though their role in screening is now debated among medical organizations because both tests can produce false alarms.

Imaging Scans Before Biopsy

If PSA is elevated or the DRE feels abnormal, a doctor may order an imaging scan to look at the prostate more closely before doing a biopsy. The most common scan is an MRI (magnetic resonance imaging), which uses magnetic fields and radio waves to create detailed pictures of the prostate. MRI can show the size and location of suspicious areas and help a doctor decide whether a biopsy is needed and where to target it.

An ultrasound may also be used, especially during a biopsy procedure itself. Ultrasound uses sound waves to create images and is often less expensive and faster than MRI. Some doctors use a combination: MRI to plan the biopsy, then ultrasound to guide the needle during the procedure. The choice depends on what your doctor thinks will give the clearest picture of your prostate.

The Prostate Biopsy

A biopsy is the definitive test. A doctor uses a thin needle to remove 10 to 12 small samples of prostate tissue, usually guided by ultrasound or MRI. The procedure takes 10 to 15 minutes and is done in an office or outpatient clinic, often with local anesthesia to numb the area. You may feel pressure or brief discomfort as the needle enters, but most men tolerate it without significant pain.

After the biopsy, you may have blood in your urine or stool for a few days, and some men have mild discomfort or a slight fever. Serious complications like infection or heavy bleeding are rare. A pathologist examines the tissue samples under a microscope and looks for cancer cells. Results usually come back within one to two weeks.

Understanding Your Biopsy Results

Biopsy results tell you whether cancer is present and, if it is, how aggressive it appears. The Gleason score is the most important number. It ranges from 2 to 10 and describes how abnormal the cancer cells look under the microscope. A lower score (like 6) means the cancer cells look more like normal prostate cells and tend to grow slowly. A higher score (like 8 or 9) means the cells look very different and are more likely to grow and spread quickly.

Your pathology report will also say how many of the tissue samples contained cancer and what percentage of each sample was cancerous. All of this information helps your doctor understand how serious the cancer is and what treatment options make sense. You may also hear the term Gleason grade group, which is a newer way of grouping Gleason scores into five categories to make the information easier to understand.

Staging Tests After Diagnosis

Once a biopsy confirms cancer, your doctor will order additional tests to see whether the cancer has spread beyond the prostate. These staging tests help determine how advanced the cancer is and guide treatment decisions. Common staging tests include a CT scan or MRI of the pelvis and abdomen to check nearby lymph nodes, and sometimes a bone scan or PET scan to look for spread to bones or distant organs.

Not every man needs every staging test. Your doctor will choose based on your Gleason score, PSA level, and other risk factors. A man with a low Gleason score and low PSA may need only imaging of the pelvis. A man with a high Gleason score or very high PSA may need more extensive imaging. Staging usually takes one to three weeks and is complete before you and your doctor discuss treatment options.

Frequently Asked Questions

How long does the whole diagnosis process take?

From your first PSA test or DRE to biopsy results usually takes four to eight weeks, depending on how quickly tests can be scheduled and how busy the lab is. Staging tests add another one to three weeks. If you are anxious about the wait, ask your doctor's office for a timeline and what to expect at each step.

Can a biopsy spread cancer to other parts of my body?

No. A biopsy needle removes only tiny samples and does not increase the risk that cancer will spread. The biopsy is necessary to confirm whether cancer is present, and the small risk of infection or bleeding is far outweighed by the benefit of knowing your diagnosis.

What if my biopsy shows no cancer but my PSA is still high?

A negative biopsy does not rule out cancer forever. Your doctor may repeat the biopsy in the future if PSA continues to rise or if imaging shows new suspicious areas. Some men have high PSA from enlarged prostate or infection, not cancer. Your doctor will discuss whether repeat testing makes sense based on your individual situation.

Do I need all three tests—PSA, DRE, and biopsy—or just some of them?

Not necessarily. Some men have only a PSA test; others have PSA plus DRE. If results are normal, no biopsy is needed. If results are abnormal, imaging and biopsy follow. Your doctor will recommend which tests are right for you based on your age, symptoms, and risk factors.

What happens if cancer is found in only one or two biopsy samples?

Even a small amount of cancer in a biopsy sample means cancer is present and needs to be discussed with your doctor. The number of positive samples and the percentage of cancer in each sample help determine how aggressive the cancer is, but even limited cancer requires a plan—whether that is active monitoring, surgery, radiation, or another treatment.